| Literature DB >> 33692771 |
Isabel Moreno-Indias1,2, Leo Lahti3, Miroslava Nedyalkova4, Ilze Elbere5, Gennady Roshchupkin6, Muhamed Adilovic7, Onder Aydemir8, Burcu Bakir-Gungor9, Enrique Carrillo-de Santa Pau10, Domenica D'Elia11, Mahesh S Desai12,13, Laurent Falquet14,15, Aycan Gundogdu16,17, Karel Hron18, Thomas Klammsteiner19, Marta B Lopes20,21, Laura Judith Marcos-Zambrano10, Cláudia Marques22, Michael Mason23, Patrick May24, Lejla Pašić25, Gianvito Pio26, Sándor Pongor27, Vasilis J Promponas28, Piotr Przymus29, Julio Saez-Rodriguez30, Alexia Sampri31, Rajesh Shigdel32, Blaz Stres33,34,35, Ramona Suharoschi36, Jaak Truu37, Ciprian-Octavian Truică38, Baiba Vilne39, Dimitrios Vlachakis40, Ercument Yilmaz41, Georg Zeller42, Aldert L Zomer43, David Gómez-Cabrero44, Marcus J Claesson45.
Abstract
The human microbiome has emerged as a central research topic in human biology and biomedicine. Current microbiome studies generate high-throughput omics data across different body sites, populations, and life stages. Many of the challenges in microbiome research are similar to other high-throughput studies, the quantitative analyses need to address the heterogeneity of data, specific statistical properties, and the remarkable variation in microbiome composition across individuals and body sites. This has led to a broad spectrum of statistical and machine learning challenges that range from study design, data processing, and standardization to analysis, modeling, cross-study comparison, prediction, data science ecosystems, and reproducible reporting. Nevertheless, although many statistics and machine learning approaches and tools have been developed, new techniques are needed to deal with emerging applications and the vast heterogeneity of microbiome data. We review and discuss emerging applications of statistical and machine learning techniques in human microbiome studies and introduce the COST Action CA18131 "ML4Microbiome" that brings together microbiome researchers and machine learning experts to address current challenges such as standardization of analysis pipelines for reproducibility of data analysis results, benchmarking, improvement, or development of existing and new tools and ontologies.Entities:
Keywords: ML4Microbiome; biomarker identification; machine learning; microbiome; personalized medicine
Year: 2021 PMID: 33692771 PMCID: PMC7937616 DOI: 10.3389/fmicb.2021.635781
Source DB: PubMed Journal: Front Microbiol ISSN: 1664-302X Impact factor: 5.640